"In vitro" antiviral effects of synthetic compounds upon DNA and RNA viruses. 1984

M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg

UI MeSH Term Description Entries
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D010093 Oxolinic Acid Synthetic antimicrobial related to NALIDIXIC ACID and used in URINARY TRACT INFECTIONS. Gramurin,Sodium Oxolinate,Acid, Oxolinic,Oxolinate, Sodium
D010893 Piromidic Acid Antibacterial against mainly gram negative organisms. It is used for urinary tract and intestinal infections. Acid, Piromidic
D004267 DNA Viruses Viruses whose nucleic acid is DNA. DNA Virus,Virus, DNA,Viruses, DNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004770 Enterovirus A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated "human enterovirus". Coxsackie Viruses,Coxsackieviruses
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
March 1982, Journal of food safety,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
January 1982, Revista latinoamericana de microbiologia,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
December 2021, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
January 1993, Comparative biochemistry and physiology. B, Comparative biochemistry,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
June 2023, Microbiology and molecular biology reviews : MMBR,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
February 2007, Antiviral research,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
September 1978, Journal of medicinal chemistry,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
June 1973, Veterinariia,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
January 1968, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
M H Lagrota, and R B Freire, and N A Pereira, and J C Gimarães, and M D Wigg
June 1977, Journal of medicinal chemistry,
Copied contents to your clipboard!